2020
DOI: 10.1007/s00223-020-00669-4
|View full text |Cite
|
Sign up to set email alerts
|

Effect of Low-Dose Vitamin K2 Supplementation on Bone Mineral Density in Middle-Aged and Elderly Chinese: A Randomized Controlled Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
9
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(10 citation statements)
references
References 42 publications
0
9
0
1
Order By: Relevance
“…In this scenario, vitamin K2 was recently identified as a family of promising fat-soluble natural compounds necessary for bone health [ 31 ]. Indeed, its capacity to reduce loss of bone mass and risk of fractures thorough their action as a cofactor of the enzyme γ-glutamyl carboxylase (GGCX) [ 32 ] has been widely demonstrated [ 13 , 14 , 15 , 33 ]. However, the exact role of vitamin K2 in bone disorders, such as osteoporosis, is poorly understood [ 34 ].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In this scenario, vitamin K2 was recently identified as a family of promising fat-soluble natural compounds necessary for bone health [ 31 ]. Indeed, its capacity to reduce loss of bone mass and risk of fractures thorough their action as a cofactor of the enzyme γ-glutamyl carboxylase (GGCX) [ 32 ] has been widely demonstrated [ 13 , 14 , 15 , 33 ]. However, the exact role of vitamin K2 in bone disorders, such as osteoporosis, is poorly understood [ 34 ].…”
Section: Discussionmentioning
confidence: 99%
“…Nutrients 2021, 13, 2823 2 of 17 Among all possible osteo-protective compounds, vitamin K2 is noteworthy [6], a family of different isoforms, known as menaquinones (MKs), which differ from each other by the number of isoprenoid units in the side chain (n = 1-14), and in the last few years, they have received attention for their positive effects in bone metabolism [7][8][9][10][11]. Although its beneficial role in decreasing bone loss and risk of osteoporotic fractures has been established [12][13][14][15], additional studies are needed to deeply understand if vitamin K2 intake would provide a valid support to prevent and treat osteoporosis or if some people may be refractory to its effects.…”
Section: Introductionmentioning
confidence: 99%
“…The body is in a straight line to maintain the movement. (5) For diagonal support of the kneeling position, take the kneeling position, first support the body with both hands and knees, straighten both upper limbs, bend both hips and knees by 90°, then straighten the left upper limb forward, extend the right lower limb backward, form a straight line with the trunk, and only support the body with the right hand and left knee [ 13 ], alternating on both sides. Each action is repeated 10 times, each action lasts for 5~10 s, and the action interval is 5~10 s. The five training movements were performed in two groups for a total of about 40 minutes (about 3 minutes for double leg bridging, about 5 minutes for bilateral alternation of single leg bridging, 3 minutes for treadmill in lying position, about 3 minutes for plate support, and about 5 minutes for bilateral alternation of diagonal support in the kneeling position).…”
Section: Experimental Analysismentioning
confidence: 99%
“…Также в отношении сохранения МПКТ поясничного отдела позвоночника у женщин в постменопаузе эффективность показала и тройная комбинация витамина K 2 в дозе 100 мкг в день, кальция в дозе 800 мг в день и витамина D в дозе 10 мкг (400 МЕ) в день [43]. Однако в недавнем рандомизированном контролируемом исследовании популяции постменопаузальных китайских женщин средних лет и в пожилом возрасте дополнительное добавление к витамину K 2 в дозе 90 мкг в день препаратов кальция (500 мг в день) и витамина D (в дозе 400 МЕ НАУЧНЫЙ ОБЗОР в день) не показало улучшения эффекта в сравнении с монотерапией витамином K 2 [44]. Единичные исследования применения витамина K 2 с антирезорбтивными препаратами, в частности с бисфосфонатами, также продемонстрировали неоднозначные результаты: так, комбинация с алендронатом была ассоциирована с повышением МПКТ в бедренной кости у женщин с постменопаузальным остеопорозом [45], в то время как комбинированная терапия с ризедронатом не показала эффективности по сравнению с монотерапией ризедронатом [46].…”
Section: влияние витамина K 2 на костную тканьunclassified